A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors.
Saved in:
| Title: | A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors. |
|---|---|
| Authors: | Kebenko M; Department of Oncology/Hematology, Bone Marrow Transplantation and Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Goebeler ME; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany., Wolf M; Clinic Kassel, Kassel, Germany., Hasenburg A; Department of Gynecology, Johannes Gutenberg University Medical Center, Mainz, Germany., Seggewiss-Bernhardt R; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany., Ritter B; Clinic Kassel, Kassel, Germany., Rautenberg B; Department of Gynecology, Johannes Gutenberg University Medical Center, Mainz, Germany., Atanackovic D; Department of Oncology/Hematology, Bone Marrow Transplantation and Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kratzer A; Amgen Research (Munich) GmbH, Munich, Germany., Rottman JB; Amgen Inc., Thousand Oaks, CA, USA., Friedrich M; Amgen Research (Munich) GmbH, Munich, Germany., Vieser E; Amgen Research (Munich) GmbH, Munich, Germany., Elm S; Amgen Research (Munich) GmbH, Munich, Germany., Patzak I; Amgen Research (Munich) GmbH, Munich, Germany., Wessiepe D; Metronomia Clinical Research GmbH, Munich, Germany., Stienen S; Amgen Research (Munich) GmbH, Munich, Germany., Fiedler W; Department of Oncology/Hematology, Bone Marrow Transplantation and Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. |
| Source: | Oncoimmunology [Oncoimmunology] 2018 Apr 18; Vol. 7 (8), pp. e1450710. Date of Electronic Publication: 2018 Apr 18 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30221040 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kebenko+M%22">Kebenko M</searchLink>; Department of Oncology/Hematology, Bone Marrow Transplantation and Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Goebeler+ME%22">Goebeler ME</searchLink>; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wolf+M%22">Wolf M</searchLink>; Clinic Kassel, Kassel, Germany.<br /><searchLink fieldCode="AU" term="%22Hasenburg+A%22">Hasenburg A</searchLink>; Department of Gynecology, Johannes Gutenberg University Medical Center, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Seggewiss-Bernhardt+R%22">Seggewiss-Bernhardt R</searchLink>; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ritter+B%22">Ritter B</searchLink>; Clinic Kassel, Kassel, Germany.<br /><searchLink fieldCode="AU" term="%22Rautenberg+B%22">Rautenberg B</searchLink>; Department of Gynecology, Johannes Gutenberg University Medical Center, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Atanackovic+D%22">Atanackovic D</searchLink>; Department of Oncology/Hematology, Bone Marrow Transplantation and Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kratzer+A%22">Kratzer A</searchLink>; Amgen Research (Munich) GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Rottman+JB%22">Rottman JB</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Friedrich+M%22">Friedrich M</searchLink>; Amgen Research (Munich) GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Vieser+E%22">Vieser E</searchLink>; Amgen Research (Munich) GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Elm+S%22">Elm S</searchLink>; Amgen Research (Munich) GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Patzak+I%22">Patzak I</searchLink>; Amgen Research (Munich) GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Wessiepe+D%22">Wessiepe D</searchLink>; Metronomia Clinical Research GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Stienen+S%22">Stienen S</searchLink>; Amgen Research (Munich) GmbH, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Fiedler+W%22">Fiedler W</searchLink>; Department of Oncology/Hematology, Bone Marrow Transplantation and Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2018 Apr 18; Vol. 7 (8), pp. e1450710. <i>Date of Electronic Publication: </i>2018 Apr 18 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30221040 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2018.1450710 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1450710 Titles: – TitleFull: A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kebenko M – PersonEntity: Name: NameFull: Goebeler ME – PersonEntity: Name: NameFull: Wolf M – PersonEntity: Name: NameFull: Hasenburg A – PersonEntity: Name: NameFull: Seggewiss-Bernhardt R – PersonEntity: Name: NameFull: Ritter B – PersonEntity: Name: NameFull: Rautenberg B – PersonEntity: Name: NameFull: Atanackovic D – PersonEntity: Name: NameFull: Kratzer A – PersonEntity: Name: NameFull: Rottman JB – PersonEntity: Name: NameFull: Friedrich M – PersonEntity: Name: NameFull: Vieser E – PersonEntity: Name: NameFull: Elm S – PersonEntity: Name: NameFull: Patzak I – PersonEntity: Name: NameFull: Wessiepe D – PersonEntity: Name: NameFull: Stienen S – PersonEntity: Name: NameFull: Fiedler W IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 04 Text: 2018 Apr 18 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 2162-4011 Numbering: – Type: volume Value: 7 – Type: issue Value: 8 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |
